G Protein-Coupled Estrogen Receptor-Selective Ligands Modulate Endometrial Tumor Growth
Endometrial carcinoma is the most common cancer of the female reproductive tract. GPER/GPR30 is a 7-transmembrane spanning G protein-coupled receptor that has been identified as the third estrogen receptor, in addition to ERα and ERβ. High GPER expression is predictive of poor survival in endometria...
Saved in:
Main Authors: | Whitney K. Petrie (Author), Megan K. Dennis (Author), Chelin Hu (Author), Donghai Dai (Author), Jeffrey B. Arterburn (Author), Harriet O. Smith (Author), Helen J. Hathaway (Author), Eric R. Prossnitz (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endometrial Cancer: Molecular and Cellular Basis of Tumor Development, Novel Biomarkers and Therapeutic Agents, and Innovative Research Approaches
by: Donghai Dai, et al.
Published: (2014) -
Peptide ligand recognition by G protein-coupled receptors
by: Brian E Krumm, et al.
Published: (2015) -
Correlation between estrogen receptor and programmed death ligand-1 in type I endometrial cancer
by: Setyo Teguh Waluyo, et al.
Published: (2024) -
Allosteric Modulation of G Protein Coupled Receptors by Cytoplasmic, Transmembrane and Extracellular Ligands
by: Naveena Yanamala, et al.
Published: (2010) -
Original Fluorescent Ligand-Based Assays Open New Perspectives in G-Protein Coupled Receptor Drug Screening
by: Thierry Durroux, et al.
Published: (2011)